Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 5CNS 5Genitourinary 4Head & Neck 3Breast 2Tumor-Agnostic 1Other solid neoplasm 1Gynecologic 1

Conditions

Thyroid Nodule 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lymphedema 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Carcinoma 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Drug Delivery Systems × Head & Neck × Clear all
NCT06117085 2024-11-21

CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules

Pulse Biosciences, Inc.

Phase NA Completed
30 enrolled
Head & Neck

Thyroid Nodule

NCT05512767 2023-01-06

A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation

Mayo Clinic

Phase NA Withdrawn
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04276454 2020-08-13

Lymphedema Treatment in Head and Neck Cancer Patients

Endeavor Health

Phase NA Withdrawn
Head & Neck

Head and Neck Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡